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Abstract 
Background:  Men affected by prostate cancer undergoing hormone therapy can endure a 
range of symptoms that can negatively impact quality of life. Little research has been 
conducted to date, to understand the specific unmet supportive care needs of this patient 
group within the context of current service delivery.    
Objective: To understand the experiences of unmet supportive care needs in men affected by 
prostate cancer on hormone therapy in the United Kingdom. 
Intervention/Methods:  Mixed methods study recruited 31 men with ≥T3 prostate cancer and 
treated by hormone therapy.  A small cross-sectional survey (EORTC C30, PR25, Self-
Management Self-Efficacy Scale and the Supportive Care Needs Survey) was used to inform 
the interview schedule.  Semi-structured interviews were conducted and framework approach 
was used to analyze the data.   
Results: A range of complex unmet supportive care needs were related to physical, 
psychological/emotional, intimacy/sexual, practical, health system/informational, existential 
and patient/clinician communication needs are experienced.  Men articulated that current 
healthcare delivery is failing to provide a holistic person-centred model of care. 
Conclusion:  This is one of the few studies that has identified the unmet supportive care needs 
of men receiving hormone therapy for ≥T3 prostate cancer. The needs are multiple and far-
ranging.  
Implications for practice:  Despite national cancer reforms, unmet supportive care needs 
persist.  The findings from this study may be central in the re-design of future services to 
optimise men’s quality of life and satisfaction with care.  Clinicians are encouraged to use 
these finding to help them optimise care delivery and individual quality of life. 
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Introduction 
Currently 250,000 men are affected by prostate cancer in the United Kingdom 1.  Data 
identifies that more males are diagnosed at an early stage (59% diagnosed at stage I or II) 
than at an advanced stage (41% diagnosed at stage III or IV). Moreover, around 1 in 5 of 
males will have metastases at diagnosis (stage IV) 2.  Men with locally advanced or 
metastatic prostate cancer where curative intent is no longer the treatment goal, face distinct 
challenges in contrast to men with localised prostate cancer 3. Male hormones, specifically 
testosterone, fuel the growth of prostate cancer. By reducing the amount and activity of 
testosterone, the growth of advanced prostate cancer is slowed and controlled, but not cured. 
Hormone therapy is the main treatment for men with disseminated prostate cancer that is 
easily administered treatment, but it is not without side-effects 4.  
 
Men undergoing hormone therapy may experience the following psychological effects: mood 
disturbance, cognitive impairment, difficulties with self-image and masculinities; physical 
effects such as hot flushes, osteoporosis, spinal cord compression, fatigue, sexual 
dysfunction, and changes in muscle mass, and adiposity 5  Similar to men with localised 
prostate cancer, men with advanced stage disease report higher levels of psychological 
distress, poorer quality of life and greater symptom burden 6.  There is evidence 
acknowledging that men affected by prostate cancer have reported a range of needs7,8 that 
include: informational needs 9,10, self-management of urological symptoms 11, psychological 
problems 12 and sexual needs 4,13-15.  Supportive care is a person-centred approach to the 
provision of the necessary services for those living with or affected by cancer to meet their 
informational, spiritual, emotional, social, or physical needs during diagnosis, treatment, or 
follow-up phases including issues of health promotion and prevention, survivorship, 
palliation and bereavement 9,16,17.   
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In the UK, and internationally, the drive to find alternative methods of service delivery in this 
patient group are demonstrated by a range of studies 18-20.   As the prevalence of prostate 
cancer increases alternative models of follow-up care are now being considered 21. Recently, 
a systematic review of the evidence 22 highlighted the substantial impact of cancer and 
treatment on long-term health and quality of life. This posed the question about the most 
appropriate configuration of health care services and follow-up models of care. However, 
patients’ perspectives and their experiences of supportive care are not well articulated within 
the existing evidence base23.   Previous research has mainly focused on symptom experience 
and quality of life using both qualitative and quantitative approaches6,24-26 but has not 
specifically addressed unmet supportive care needs experienced within existing health 
services.  Two recent systematic reviews 8,27 concluded that  there is a dearth of research to 
help guide clinicians on the supportive care needs of men undergoing hormone therapy, and 
to optimise a person-centred, holistic model of shared care for these men.  We need further 
understanding as to why unmet supportive care needs persist in current care delivery in the 
UK, despite national cancer reforms to improve and optimise supportive care 28 for people 
living with prostate cancer.   
 
This is the first study to address, what are the experiences of unmet supportive care needs in 
men affected by prostate cancer on hormone treatment in current healthcare? 
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Study design, sample and methods 
Institutional ethical approval (Caldiott/CSAppGN021211) was granted for this mixed 
methods study and was conducted in line with the consolidated criteria for reporting 
qualitative research (COREQ) 29.  Participants were recruited into the study based on the 
following inclusion criteria: 1) diagnosed with >T3 prostate cancer on hormone therapy, 2) 
adults (≥18 years), 3) deemed physically/psychologically well to participate in the study by a 
member of the clinical multidisciplinary team, and 4) able to understand and communicate in 
the English language.  Exclusion criteria: 1) patients unable to meet the inclusion criteria and 
2) unable to provide written informed consent.  Participants were recruited from a main 
cancer center in Scotland, UK. 
 
A total of thirty-five men were invited, of which thirty-one men consented to participate 
(88.6% response rate).  Reasons for non-participation included feeling unwell as a result of 
treatment (n=2), and not interested (n=2).  Patients (n=31) were sent a postal questionnaire by 
a member of their healthcare team and a stamped, addressed return envelope, to inform the 
development of the interview topic guide for the qualitative component of this study.  
 
Variables 
Age, socio-economic (Scottish Index of Multiple Deprivation [SIMD]), cancer stage, 
prostate specific antigen (PSA) and co-morbidities were collected from case records.   
Supportive Care Needs Survey  
The Supportive Care Needs Survey (SCNS) 30 is an instrument for assessing the perceived 
needs of people diagnosed with cancer.  The 34 items are mapped to the following five 
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domains: psychological, health system, physical and daily living, patient care and support, 
and sexuality.  Reliability and validity of this instrument has been previously 
demonstrated, including with men on treatment for prostate cancer 30,31. 
Self-management Self-Efficacy Scale (SE Scale)  
The SE Scale 32 provides an assessment of participants’ belief and confidence to perform 
their self-management.  Self-efficacy is a general term used to describe the belief that one can 
perform a novel or a difficult task, or cope with adversity in various domains of human 
functioning.    Reliability and validity of the general self-efficacy scale has been 
demonstrated previously 32.  No normative data exists for this questionnaire.    
 EORTC Quality of Life (QLQ C30) Prostate module (PR25)  
The QLQ C30 33 and the PR25 34 comprise an integrated measurement system for HRQoL in 
cancer participants.  Reliability and validity of the QLQ C30 33 and the PR25 34 have been 
demonstrated previously.  Normative data is available for the QLQ C30 detailed in Table 1 
for a heterogeneous sample (all prostate cancer stages), but no normative data is available for 
the PR25. 
Interview Design 
Data were collected between January and May 2015.  Exploratory semi-structured interviews 
were conducted using a topic guide informed by existing literature, the original research 
question, the questionnaire data from the 31 respondents and the classification of supportive 
care needs 8,9,16,17 (Table 2).   Purposive sampling of the interviews (n=8) ensured maximum 
variation by: patients’ age (67-84 range), socio-economic background (SIMD 1-5), time since 
diagnosis (April 2013 – November 2014) and prevalence of the number of existing co-
morbidities (0-5 range).  The study sample was designed to enable the researchers to explore 
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some diversity in men’s experiences of follow-up care.  The study’s multidisciplinary team 
included a Senior Prostate Cancer Specialist Nurse (CP) and a Professor of Surgical Uro-
Oncology/Consultant Urological Surgeon with special interest in prostate cancer (GN) who 
commented on emergent themes and areas that might be worthy to probe in subsequent 
interviews.  The common themes were continually reviewed.  Field notes were written 
immediately following the interviews to record any unrecorded conversations before and 
after the “formal” interview.   
Description of Interview 
All interviews were conducted in the participants’ homes by CP, who was responsible for the 
overall research process.  Interviews were digitally recorded with the patient’s written 
consent.  The interviews began with an open-ended, non-directive question to encourage the 
men to speak about their experiences of their follow-up care.  Open-ended probe questions 
were also used to elicit greater detail of experiences shared by participants (Table 3). 
Analysis of qualitative and quantitative data  
The in-depth, semi-structured interviews lasted 40-90 minutes.  Recordings were transcribed 
verbatim, cross-checked for accuracy and identifying information removed.  CP coded all of 
the interviews and coding was subsequently verified by GN, ensuring a close match.  
Framework Analysis 35 was used to examine commonalities and differences within and 
between the transcripts.  Broad themes were identified first and then broken down in to sub-
themes.  An electronic matrix display (in Microsoft Excel) was used to keep a transparent 
account of how themes were derived and this display included original links to the data.  
Triangulation strategies included comparison of the study results with those in previous 
studies conducted in the patient population 9,12,35 and with the data collected from the 
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questionnaire survey (n=31).  The questionnaire data were analyzed using traditional 
exploratory analysis and descriptive statistics 36 in SPSS version 21.   
Results 
Thirty-one men participated in the cross-sectional survey (Table 4) and eight men took part in 
the in-depth interviews (Table 5).  The mean age of the study participants was 80.1 years (SD 
6.9).  Men reported lower levels of self-efficacy 3.3, (SD .9) when compared to other  
published data 37 that may have influenced the experience of unmet supportive care needs in 
this patient population.  Questionnaire data identified that men reported a range of symptoms 
(urinary, fatigue, pain, and bowel), reduced quality of life (Table 4).  When compared to 
normative data (Table 1) the current study population reported lower functional outcomes 
that included: physical function, role function, cognitive function, but higher emotional and 
cognitive function.  Men reported higher levels of diarrhoea, but less symptomology on all 
other scales when compared to normative data.  Despite being a relatively small sample of 
men (n=31) men reported a range of unmet supportive care needs related to the fear of cancer 
spreading (n=13, 41.9%), lack of energy/tiredness (n=10, 32.3%), worry that the results of 
treatment are beyond your control (n=9, 29%), uncertainty of the future (n=9, 29%), and 
being given inadequate information (n=9, 29%) see Table 6.   Interestingly, men further 
articulated these specific unmet needs and shared their experiences in greater depth in the 
qualitative findings.  
 
Psychological/Emotional Consequence 
Men spoke about uncertainty, worry and emotional needs of living with advanced prostate 
cancer and the impact at diagnosis:  
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“he [consultant] said well I have got your results and they are bad news, they have spread.  
Gasp, then I take a deep breath, and I asked where it has [cancer] spread to?  The reply was 
everywhere.  I mean what does that mean, I was left in complete shock.  No support, no nurse 
to speak to help me understand what everywhere meant, so I thought I only have a few weeks 
to live before I die” (#3, 77 years).   
Men emphasised the need for emotional support at hospital appointments:  
“… you know you get yourself all in a stutter, and what you have been told, you forget as you 
only focus on what is ahead of you … you need somebody with you, you need two [people], or 
a nurse to take you through what the doctor has just told you” (#2, 76 years).   
This was a similar experience to another man:  
“I thought they were going to do something with the catheter, I didn’t realize I was getting 
the results, so of course I got the results on my own, didn’t take everything in, well obviously 
somebody has just confirmed to you that you have got terminal cancer it’s a bit of you know, 
a kick in the stomach, my wife should have been with me” (#5, 67 years).   
Another man expressed his need to see a nurse for additional support:  
“I was not offered to speak things over with the nurse, to soften the blow so to speak, or to 
understand what I was just told” (#3, 76 years). 
 
Physical symptoms 
The majority of men described symptom experiences of weight gain, hot flushes, fatigue and 
weakness.  This had a minor consequence on their quality of life, and was accepted as part of 
living with cancer and treatment.  However, some men expressed a negative impact of their 
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symptoms on daily life as a result of pain and urinary symptoms and according to one 
participant:  
“I can only sleep about 2 or 3 hours at a time …and  I am back up for the loo [void] all night.  
It’s this arm, and then this hip, em and sometimes this shoulder that is sore during the night” 
(#8, 74 years).   
Another man spoke about his initial experience of bone pain:  
“the pain was terrific in my back, and then I had to go onto the patches, but it is controlled 
now.  I needed to keep asking my GP for help, I couldn’t even get out of my bed, and it was a 
problem as how could I even get to the toilet?  I mean I felt helpless with this pain, and 
affected my wife too seeing me like this” (#7, 84 years).  
Men spoke about the functional issues of their symptom burden:  
“if I want to go out, the biggest problem is that with the water works … when I need shopping 
I need to wait until the afternoon to do that, as there are no toilets nowadays, half of them are 
shut.  So your confidence is affected, as if you are desperate when you need to go, you need to 
go” (#6, 79 years). 
Interpersonal/Intimacy  
Some men experienced unmet sexual needs but for other men they felt that they were too old 
to think about or bother with sex.  Older participants appeared to accept that treatment had 
brought their sex lives to a halt permanently, and were unlikely to pursue further treatment to 
restore or improve their sexual function:  
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“I have no libido, I am too old I think, I am 79. Interviewer: does that bother you or is it a 
concern to you? No not all, I would not say that my wife is all of that keen [laughing], she is 
late 70 as well, and so it doesn’t bother us.  I think she is happier [laughing]” (#6, 79 years).   
 
Age, however, was not always correlated to the experience of unmet sexual needs as 
identified from this 82 year old man:  
 
“She is [wife] actually quite wonderful and must be very frustrating for her living with me, 
my sex life has just disappeared, but I think they are going to give me a pill.  I no longer have 
the urge but my wife is 15 years younger than me, so I need to make her happy, that I am still 
a man” (#1, 82 years). 
 
Another man spoke about the impact of his reduced sexual function on his quality of life:  
“to be honest with getting older I have less urges to chase women around, and he 
(consultant) says that will happen with this treatment, you just lose the urge for a bit of 
dalliance.  Interviewer: Does this impact upon your quality of life? Well, yes it does 
particularly whilst on holidays and wanting a good time if you know what I mean” (#5, 67 
years).   
 
Some men also had limited understanding about the options available for their erectile 
dysfunction, and some expressed worries that intervention would worsen their prognosis:  
“There is none, and getting an erection is [an] impossibility, after the first injection there was 
a limited activity, but the second one, then nope, nothing. Interviewer: Can you tell me more 
about that?  Well actually, what I thought was and what I was frightened of, was that if I 
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improved that aspect of things, it was impinge on the other [prostate cancer treatment]” (#3, 
77 years).   
 
Men also spoke about changes in their masculinity and body image:  
 
“ … It like the testes, I mean do they go smaller? Interviewer: Have you noticed this? oh yes, 
the testes are definitely down, shrunken wee [little] things now.  I don’t know why they just 
don’t take them out” (#6, 79 years). 
 
 
Practicality of Living with Prostate Cancer and Treatment  
A common need across the men was difficulties in attending out-patient clinics due to 
reduced mobility and difficulties with hospital transportation.   
 
“It is a struggle … I have got a niece and she is affa [awful] obliging, she took me, and then 
my neighbour took me, because we have got a car that I am not able to drive anymore, it is 
sitting in the garage, and it was a new car.  I was advised not to drive anymore because the 
bones are so, in case I have to break suddenly with my bones being so weak.  I do miss the 
car.  It was a long day with patient transport, and I was up to ninety-nine [very anxious], 
with nobody to take me there, and no lunch, my wife could not come in the patient transport 
either with the insurance or something” (#7, 84 years). 
 
Other practical needs men spoke about were in relation to getting holiday insurance [travel 
insurance for going on vacation] as consequence of having prostate cancer:   
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“I want to get away on holiday again, you know, but I find it hard to get insurance that is the 
trouble. Interviewer: Can you tell me more about what makes it challenging? Age is for a 
start, and then you say I have got prostate cancer, and then they say oh, I can’t cover you for 
that, or it will cost you £3000 quid [pounds] you know … it is a substantial amount of money, 
and I think that they just didn’t want to cover me, you know, at that price” (#8, 74 years).   
Existential Concerns 
Men spoke about their concerns of their prognosis and a lack of information about what 
happens next in their care.    
“Nobody has told me prognosis or anything, you know, because what got me was that they 
told me it was stage four, and it was aggressive, how long have I got you know?  Nobody told 
me or what is going to happen next” (#5, 67 years).   
Another man shared his experience of his need to see his GP immediately following his 
hospital appointment due to fears of death and dying:  
“I went immediately to my doctor [General Practitioner] at home and we were able to talk 
through things, and you know, I asked him the question, how long have I got, because that 
was my immediate reaction, because according to my consultant it was everywhere! 
Everywhere …uch [sigh] you know when I was going home in the car I started to think right 
… we have got 2 cars, well what we will do, is keep one car and get rid of the other car and 
put the car in my wife’s name, and sort out my money in my account, we will pay that and 
this, and you know that is what I felt at the time” (#3, 77 years). 
Another man also expressed existential concerns:  
“It was a shock, I don’t know how long you have prostate cancer for before it affects you and 
you die? I never thought about dying before, even though when you were getting into your 
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eighties, you know, you push it towards the back of your mind.  But eh, now I have to bring it 
forward and life goes on whether you are there or not” (#6, 79 years). 
 
 
Lack of Health System/Information  
 Many of the men reported a lack of understanding and information about prostate cancer, 
diagnosis and treatment.  Men were given various levels of written information in some basic 
leaflets and others were provided with more comprehensive information booklets.  There is a 
need to tailor information to each individual man, as according to one man:  
“oh it was a lot of information right enough, I initially knew what was going on, but em, now 
I don’t know what is going on; it was too much information” (#7, 84 years).    
Men also spoke about a lack of information about the potential of side-effects from their 
healthcare team:  
“Well when I got the hot flushes, and then everything shrivelled [testes] up I wasn’t given 
any information, but then I went up to them [healthcare professionals] they said that this is 
expected, but I didn’t know this at the time” (#6, 79 years).   
Men also spoke about the need for on-going information support: “I got that booklet and 
after you get it you start reading, you know, and you understand a wee (little) bit more, and 
then you have got questions to ask.  I did phone my consultant because I felt as if I was being 
left kind of high and dry” (#7, 84 years).   
Many of the participants did ask specific questions of the interviewer, such as:  
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“Why do I get the blood test done, what is it called [PSA] checked? … I never know what the 
result is, that is never discussed, I don’t know any figures or that.   Interviewer: Would you 
want to know? Oh yes I would” (#5, 67 years).   
Men also spoke about difficulties in understanding the information discussed with members 
of their care team during clinical consultations:  
“the way they talk and the way we talk is two different ways.  Speaking in a jargon that a run 
of the mill person does not understand” (#2, 76 years). 
Improvement in Clinician/Patient Communication  
For some men they felt the quality of the communication with their care team, and conveying 
empathy needed improvement to optimize supportive care:  
“all that I would say is when bad news is being given, it is so important to have a 
compassionate consultant to impart that information, but also back up nurses who can take 
them away from there to understand the information, and take them somewhere quiet to talk 
them through em, because very often when you get that news you can’t hear everything, all 
that you hear is that you have cancer and its spread, and it’s here, there and there, and 
wherever.  You don’t hear anything else, and having a nurse specially trained and has 
empathy, I would definitely suggest that is something to look at.  I think for other people it 
has to be addressed, no empathy” (#3, 77 years).   
Other men spoke about a lack of holistic supportive care during their clinical consultation: “I 
already get that blood sample, and they check it and he tells me if it is up or down, last time 
he said it was up a bit, I don’t know what up is, but something, and basically that is it.  
Interviewer: How long do you see your consultant for? Oh about 10 minutes at the most, it 
takes me longer to walk in and out to get the taxi, rather than the time I am in there.  
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Interviewer: What else do they discuss, can you tell me more? They honestly don’t really 
discuss anything more; he checks the blood and then see you in 3 months or so” (#4, 81 
years).   
Improvements in Service Delivery 
The research team asked the men about their current experience of care and suggestions for 
improvement.  For the most part men were satisfied overall with their care, but there were a 
number of suggestions in relation to: a) ensuring that the clinical team has empathy and 
compassion, b) tailored informational support including self-management advice that is easy 
to understand, c) having greater access to cancer nursing specialists: “Well I don’t know if 
you have a specialist nurse to inform and keep in touch with you, even just a quick phone call 
to ask how are you, if you don’t need and you are fine, but at least to have the option.  I think 
that would be good and you know you are not on your own” (#5, 67 years), d) ensuring 
accurate communication between primary and secondary care: “I really just want to make 
sure that my GP is told everything that is going on” (#8, 74 years), and e) offering holistic 
person-centered supportive care as identified across a number of sub-themes: physical needs, 
psychological/emotional needs, intimacy/sexual needs, practice needs, health 
system/informational needs, existential needs, patient/clinician communication. 
Discussion 
This mixed methods study aimed to understand the diverse supportive care needs of men 
diagnosed with prostate cancer and treated with hormone therapy within the context of 
current service delivery.  This study is timely to understand any existing unmet needs of 
people affected by cancer given our national and international cancer reforms.  The findings 
identified that men experienced a range of unmet supportive care needs and reduced scores of 
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self-management self-efficacy 37.  These findings may serve to target translational research in 
the future, with clear implications for clinical practice.  Men affected by prostate cancer on 
hormone therapy have areas of high unmet needs, and this was particularly relevant to men’s 
psychological and existential needs around the time of diagnosis and into treatment.  Men 
spoke about uncertainty for the future, feelings of death and dying, and fear of the cancer 
spreading, which is a consistent experience of living with cancer as a chronic illness 38.  
Importantly, the findings from this study have identified that the current care delivery is 
failing to provide a holistic person-centered model of supportive care, with some men 
articulating a lack of empathy, compassion and access to specialist cancer nurses, and these 
findings are in keeping with existing evidence 8,15 .  Moreover, men reported a range of unmet 
needs in relation to physical, intimacy/sexual, practical, health system/informational needs, 
existential concerns, emotional and psychological needs, and patient/clinician 
communication8,10,39. 
This study makes an important contribution to the understanding of the role of supportive 
care in optimizing quality of life, reducing distress and improving overall satisfaction with 
the care.  Men articulated the need for future delivery of care to have involvement and access 
to cancer specialist nurses to address areas of unmet needs, a need also identified elsewhere 
40.  Nurse-led care and co-ordination roles have been promoted as an important component of 
cancer services 41 and nurses are already providing follow-up clinics for patients with prostate 
cancer as part of the multi-disciplinary approach as suggested in clinical guidelines 21 to 
provide continuity of care for patients and their family, provide information, education and 
support, be accessible to patients and their family and to release consultant time 42,43. 
This study provides comprehensive data to understand the complex patient-specific multi-
faceted unmet needs that are experienced in current care provision in this particular patient 
16 
 
group.  These findings are an essential precursor to inform the appropriate configuration of 
future service delivery.  It is commonly asserted that the patients’ perspective should inform 
clinical decision-making and direct collection of outcome data from the patient should be 
incorporated in clinical practice 44-47.  Patient-reported outcome measures (PROMs) are 
described as standardized, validated questionnaires that are completed by patients to measure 
their perceptions of their needs, quality of life and symptom burden 44.  Emergent evidence 
supports the routine use of PROMs to help to drive changes in how healthcare is organized 
and delivered, but also at the “individual patient perspective” to empower men to share and 
identify areas of unmet needs during clinical consultation.  Enabling healthcare providers, 
such as cancer specialist nurses with the necessary education and training, could help provide 
person-centered interventions that enable a “participatory person-centred model of care” in a 
timely and effective manner 48.    Moreover, a recent systematic review 8 has identified that 
the Supportive Care Needs Survey  30,31  would be suitable for use in routine clinical practice 
as this instrument identifies unmet supportive care needs, and has demonstrated reliability 
and validity in men affected by prostate cancer.   
 
Limitations 
The qualitative methods were particularly useful in identifying the limitations within the 
current follow-up services, as described by patients in a main cancer center in Scotland.  By 
purposive sampling of patients who had experienced varying times since diagnosis, age, 
socio-economic status, number of existing co-morbidities, we were able to explore some 
diversity in men’s experiences which was strength to the study.  There were a few 
shortcomings however, and one of which is the cross-sectional design; hence our knowledge 
is limited to a “snap-shot”.  As the population of men affected by prostate cancer increases, 
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and the need for monitoring and management, we need to understand how supportive care 
needs change over time, to enable healthcare professionals to target effective and appropriate 
intervention in a timely manner.  A further limitation is that of retrospective memory recall 
bias in the assessment of supportive care needs.  Retrospective questionnaires and interview 
techniques are prone to errors and biases as a result of autobiographical memory, as this 
places demands on participants to accurately recall their experiences (that is to say, for 
example, over the past month) 49,50.  Consequently, the “real life” validity of the data is 
unknown.  However, this study is one of the first to detail the unmet supportive care needs as 
voiced by men affected by locally advanced or metastatic prostate cancer treated with 
hormone therapy in the UK.  
Conclusion    
The study identified that men with prostate cancer treated with hormone therapy experienced 
a range of complex unmet supportive care needs.  Our findings can inform translational 
research that aims to deliver a multimodal supportive care intervention tailored at the 
“individual level of need”.  However, in the meantime, healthcare professionals are 
encouraged to reflect upon these findings to ensure a holistic and person centred care 
delivery, for each and individual man. 
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Table 1 Normative data for the EORTC C30  
Constructed scales Mean (SD) Median IQR 
Global health 
status/quality of life 
Global health status/QOL 
Functional scales 
Physical functioning 
Role functioning 
Emotional functioning 
Cognitive functioning 
Social functioning 
Symptom scales / items 
Fatigue 
Nausea and vomiting 
Pain 
Dyspnoea 
Insomnia 
Appetite loss 
Constipation 
Diarrhoea 
Financial difficulties 
  
 
 
68.4 
 
80.2 
82.7 
76.6 
83.2 
80.2 
 
26.9 
5.1 
23.3 
16.8 
24.5 
10.4 
14.6 
8.4 
9.0 
 
 
(22.2) 
 
(25.6) 
(28.2) 
(23) 
(20.8) 
(27.2) 
 
(26.6) 
(14.2) 
(30.3) 
(25.7) 
(30.5) 
(23.6) 
(27.2) 
(19.4) 
(21.5) 
 
 
66.7 
 
93.3 
100 
83.3 
83.3 
100 
 
22.2 
0 
0 
0 
0 
0 
0 
0 
0 
 
 
[50-83.3] 
 
[66.7-100] 
[66.7-100] 
[66.7-100] 
[66.7-100] 
[66.7-100] 
 
[0-44.4] 
[0-0] 
[0-33.3] 
[0-33.3] 
[0-33.3] 
[0-0] 
[0-33.3] 
[0-0] 
[0-0] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
Table 2. Classification of the 11 Domains of Supportive Care Needs 
Domain of Need Definition  
Physical Needs 
 
Psychological/emotional needs 
 
Family-related needs 
Social Needs 
Interpersonal/Intimacy needs 
 
Practical Needs 
Daily Living Needs 
Spiritual/Existential Needs  
Health System/Information 
 
Patient-Clinician Communication Needs 
 
Cognitive Needs 
Experience of physical symptoms such as fatigue, urinary symptoms, bowel symptoms, pain, 
hot flushes, etc. 
Experience of psychological/emotional symptoms such as anxiety, depression, worry, despair, 
fear, etc. 
Experience of fears/concerns for the family, dysfunctional relationships, etc. 
Experience of reduced social support, social isolation, loneliness, etc. 
Experience of difficulties with self-image and masculinities, reduced libido, erectile 
dysfunction, compromised intimacy with partner, fertility, etc  
Situations of transportation, out-of-hours access to healthcare, financial support, etc 
Experience of restriction in daily living tasks such as  exercise,  housekeeping, etc 
Existential concerns such as fear of death, death and dying, fears regarding afterlife, etc  
Experience of a lack of information, uncertainty of follow-up care, lack of information in 
relation to treatment and diagnosis, etc 
Quality of communication between patients and healthcare professionals, satisfaction with 
care, shared decision-making, etc 
Experience of cognitive impairments, memory loss, etc. 
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Table 3. Interview Topic Guide 
• Can you tell me about the care and treatment that you have received? 
• Can you tell me what you think about the care you have received from healthcare professionals (at the hospital [doctors, nurses, 
AHP’s], in the community [GP’s, community nurses, practice nurses] and out-of-hours (NHS 24)? 
• Experiences of co-ordinating hormone injections, taking tablets? 
• Experiences of living with the side-effects?  Do you talk about the side-effects with your care team? If not, why not? 
• What information have you been provided with about prostate cancer, treatment and potential side-effects? 
• In general, how do you feel about the support that you have received from your healthcare providers? 
• Positive experiences of follow-up care? 
• What happens at your hospital appointments? What are you asked about? PSA results? How frequently? Who gives your injections? 
Takes your bloods? Who gives you the results?  
• Are there any improvements that might be made that could have enhanced the care that you received? 
• What could have been done better for you? 
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Table 4 Participant Characteristics of the Small Cross-Sectional Survey 
Variables N (%) 
SIMD*                                                                    
1 
2 
3 
4 
5 
n=5 (16.1%) 
n=2 (6.5%) 
n=4 (12.9%) 
n=12 (38.7%) 
n=8 (25.8%) 
Clinical Stage: 
cT3NxN0 
cT3NxN1b 
cT4NxN1b 
 
n=4 (12.9%) 
n=17 (54.8%) 
n=10 (32.3%) 
 
Mean SD 
Age 80.1 6.9 
PSA (most recent) 26.9 51.6 
Number of co-morbidities 2.1 1.6 
Date of diagnosis (years) 1.7  .9 
EORTC C30 
Quality of Life 69.6 23.9 
Physical Function 78.0 25.1 
Role Function 66.7 24.2 
Cognitive Function 66.7 22.3 
Emotional Function 88.2 16.9 
Social Functioning 85.3 16.5 
Fatigue 26.1 20.0 
Nausea and Vomiting 1.9 8.1 
Pain 11.8 19.3 
Dyspnoea 11.8 23.4 
Insomnia 17.6 29.1 
Appetite Loss 5.8 13.1 
Constipation 5.9 13.1 
Diarrhoea 17.6 23.9 
Financial  3.9 11.1 
EORTC PR25 
Urinary Symptoms 24.3 20.6 
Bowel Symptoms 6.4 8.6 
Hormone Related Symptoms 12.7 9.8 
Sexual Activity 15.7 24.6 
Self-Management Self-Efficacy 3.3 .9 
N=17, high score for a functional scale represents a high / healthy level of functioning, a high score for the global health status / QoL 
represents a high QoL, but a high score for a symptom scale / item represents a high level of symptomatology / problems (0-100)* (1 most 
deprived, 5 Least deprived)    
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Table 5 Participant characteristics of the semi-structured interviews 
Name Age Diagnosed Clinical Stage Co-morbidities PSA 
(Recent) 
SIMD (1 most 
deprived, 5 Least 
deprived) 
#1 82 August 2014 cT3NxM1b Type 2 diabetes, progressive CKD 4, 
Hypertension 
10.7 ug/L 2 
#2 76 August 2014 cT3NxM1b CKD stage 3, IHD, Type 2 diabetes, 
hypertension, AF 
10.7 ug/L 4 
#3 77 September 2014 cT3NxM1b  22.4 ug/L 3 
#4 81 October 2013 cT3NxM1b OA knees 77.0 ug/L 4 
#5 67 January 2014 cT3NxM0  45.4 ug/L 2 
#6 79 November 2014 cT3NxM1b  76.9 ug/L 4 
#7 84 November 2014 cT4 cNXN1b Hypertension, IHD, Depression 7.8 ug/L 1 
#8 74 April 2013 cT3NxM1b  1.6 ug/L 5 
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Table 6 Distributions of Unmet Supportive Care Needs  
Unmet Need* This was not a problem 
for me as a result of 
cancer. N (%) 
I did need help with this, 
but my need for help was 
satisfied at the time N (%) 
Low unmet need. I had 
little need for additional 
help. N (%) 
Moderate unmet need. I 
had some need for 
additional help. N (%) 
High unmet need.  I 
had strong need for 
additional help. N (%) 
Pain 20 (64.5%) 6 (19.4%) 2 (6.5%) 2 (6.5%) 1 (3.2%) 
Lack of energy/tiredness 12 (38.7%) 9 (29%) 6 (19.4%) 2 (6.5%) 2 (6.5%) 
Feeling unwell a lot of the time 20 (64.5%) 8 (25.8%) 2 (6.5%) 0 (%) 1 (3.2%) 
Work around home 25 (80.6%) 4 (12.9%) 1 (3.2%) 0 (%) 1 (3.2%) 
Not being able to do the things that you used 
to do 
15 (48.4%) 10 (32.3%) 3 (9.7%) 1 (3.2%) 2 (6.5%) 
Anxiety 22 (71.0%) 3 (9.7%) 4 (12.9%) 1 (3.2%) 1 (3.2%) 
Feeling down or depressed 19 (61.3%) 5 (16.1%) 5 (16.1%) 1 (3.2.%) 1 (3.2%) 
Feelings of sadness 20 (64.5%) 6 (19.4%) 4 (12.9%) 1 (3.2%) 0 (%) 
Fear about the cancer spreading 11 (35.5%) 7 (22.6%) 8 (25.8%) 3 (9.7%) 2 (6.5.%) 
Worry that the results of treatment are 
beyond your control 
17 (54.8%) 5 (16.1%) 6 (19.4%) 2 (6.5%) 1 (3.2%) 
Uncertainty about the future 15 (48.4%) 7 (22.6%) 8 (25.8%) 0 (%) 1 (3.2%) 
Learning to feel in control of your situation 18 (58.1%) 6 (19.4%) 5 (16.1%) 0 (%) 2 (6.5%) 
Keeping a positive outlook 16 (51.6%) 12 (38.7%) 2 (6.5%) 1 (3.2.%) 0 (%) 
Feelings about death and dying 14 (45.2%) 10 (32.3%) 5 (16.1%) 1 (3.2%) 0 (%) 
Changes in sexual feelings 17 (54.8%) 7 (22.6%) 5 (16.1%) 1 (3.2%) 1 (3.2%) 
Changes in sexual relationships 17 (54.8%) 7 (22.6%) 4 (12.9%) 2 (6.5%) 1 (3.2%) 
Concerns about the worries of those close to 
you* 
15 (48.4%) 7 (22.6%) 4 (12.9%) 3 (9.7%) 1 (3.2%) 
More choice about which cancer specialist to 
see 
13 (41.9%) 10 (32.3%) 5 (16.1%) 2 (6.5%) 1 (3.2%) 
More choice about which hospital you attend 18 (58.1%) 13 (41.9%) 0  (%) 0  (%) 0  (%) 
Reassurance by medical staff that the way 
you feel is normal 
18 (5.1%) 9 (29.0%) 2 (6.5%) 2 (6.5%) 0 (0%) 
Hospital staff attending promptly to your 
physical needs 
17 (54.8%) 12 (38.7%) 0 (0%) 2 (6.5%) 0 (%) 
Hospital staff acknowledging, and showing 
sensitivities  to your emotional needs 
17 (54.8%) 12 (38.7%) 0  (%) 2 (6.5%) 0  (%) 
Being given written information about the 
important aspects of your care 
13 (41.9%) 11 (35.5%) 5 (16.1%) 1 (3.2%) 1 (3.2%) 
Being given information (written diagrams, 
drawings) about managing your illness and 
side-effects at home 
15 (48.4%) 7 (22.6%) 7 (22.6%) 1 (3.2%) 1 (3.2.%) 
Being given explanations for those test for 
which you would like explanations 
15 (48.4%) 9 (29.0%) 5 (16.1%) 1 (3.2%) 1 (3.2%) 
Being adequately informed about the benefits 15 (48.4%) 9 (29.0%) 5 (16.1%) 1 (3.2%) 1 (3.2%) 
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and side-effects of treatment before you 
choice to have them 
Being informed about test results as soon as 
feasible 
13 (41.9%) 10 (32.3%) 3 (9.7%) 4 (12.9%) 1 (3.2%) 
Being informed about cancer that is under 
control or diminishing  
15 (48.4%) 9 (29.0%) 5 (16.1%) 2 (6.5%) 0 (%) 
Being informed about the things that you can 
do to get well 
16 (51.6%) 9 (29.0%) 4 (12.9%) 2 (6.5%) 0 (%) 
Having access to professional counselling 18 (58.1%) 8 (25.8%) 3 (9.7%) 1 (3.2%) 1 (3.2%) 
Being given information about sexual 
relationships 
25 (80.6%) 3 (9.7%) 3 (9.7%) 0  (%) 0 (%) 
Being treated like a person not just another 
case 
14 (45.2%) 13 (41.9%) 3 (9.7%) 1 (3.2%) 0 (%) 
Being treated in a hospital or clinic that is 
physically pleasant as possible 
14 (45.2%) 14 (45.2%) 1 (3.2%) 2 (6.5%) 0 (%) 
Having one member of hospital staff with 
whom you can talk to  
14 (45.2%) 10 (32.3%) 5 (16.1%) 1 (3.2%) 1 (3.2%) 
 
 
 
 
 
